Content about HIV

July 30, 2012

If you're a student of pharmacy today, this is what you have to look forward to in the retail pharmacy setting: working with local, state and national health departments on creating market-driven disease state management programs; actually practicing what your professors have been preaching over the past six years; applying patient management skills over prescription adjudication skills; and making a real difference in your patients' lives.

WHAT IT MEANS AND WHY IT'S IMPORTANT — If you're a student of pharmacy today, this is what you have to look forward to in the retail pharmacy setting: working with local, state and national health departments on creating market-driven disease state management programs; actually practicing what your professors have been preaching over the past six years; applying patient management skills over prescription adjudication skills; and making a real difference in your patients' lives.

July 24, 2012

Walgreens on Tuesday announced plans to work with the Department of Health and Human Services on the development of a medication therapy management program to help improve outcomes for HIV patients.

DEERFIELD, Ill. — Walgreens on Tuesday announced plans to work with the Department of Health and Human Services on the development of a medication therapy management program to help improve outcomes for HIV patients. The multiyear program will examine the impact of MTM intervention in the community pharmacy setting, with Walgreens anticipating to provide nearly $1 million in in-kind services.

July 16, 2012

Stopping a viral pandemic of any kind presents a major challenge that historically has often taken decades or even centuries, as occurred in the cases of polio and smallpox. But stopping or even slowing a pandemic is made all the more difficult when people who carry the virus face stigma and ignorance from their families, communities and governments.


Stopping a viral pandemic of any kind presents a major challenge that historically has often taken decades or even centuries, as occurred in the cases of polio and smallpox. But stopping or even slowing a pandemic is made all the more difficult when people who carry the virus face stigma and ignorance from their families, communities and governments.


July 16, 2012

The Food and Drug Administration has approved a drug used to treat HIV for reducing the risk of HIV infection, the agency said Monday.

SILVER SPRING, Md. — The Food and Drug Administration has approved a drug used to treat HIV for reducing the risk of HIV infection, the agency said Monday.

July 9, 2012

After it was first identified as the cause of AIDS in 1983, being diagnosed with an HIV infection was a literal death sentence, and it remains that way for many people in poor countries who lack access to the life-saving medications that have transformed HIV from a sure ticket to death into a chronic illness.

WHAT IT MEANS AND WHY IT'S IMPORTANT — After it was first identified as the cause of AIDS in 1983, being diagnosed with an HIV infection was a literal death sentence, and it remains that way for many people in poor countries who lack access to the life-saving medications that have transformed HIV from a sure ticket to death into a chronic illness.

July 6, 2012

All drugs provided to HIV and AIDS patients under the District of Columbia's AIDS Drug Assistance Program will go through a new pharmacy network that includes Walgreens, the D.C. Department of Health said.

WASHINGTON — All drugs provided to HIV and AIDS patients under the District of Columbia's AIDS Drug Assistance Program will go through a new pharmacy network that includes Walgreens, the D.C. Department of Health said.

July 3, 2012

The Food and Drug Administration has approved over-the-counter sales of a test for the virus that causes AIDS, the agency said Tuesday.

SILVER SPRING, Md. — The Food and Drug Administration has approved over-the-counter sales of a test for the virus that causes AIDS, the agency said Tuesday.

The FDA announced the approval of the OraQuick In-Home HIV Test, calling it the first OTC, self-administered HIV test kit that detects the presence of antibodies to HIV, including the HIV-1 and HIV-2 strains.

July 2, 2012

Retail pharmacies have been offering testing for diseases ranging from high cholesterol to cancer for years, but offering HIV testing presents a whole new realm of possibilities and challenges.

WHAT IT MEANS AND WHY IT'S IMPORTANT — Retail pharmacies have been offering testing for diseases ranging from high cholesterol to cancer for years, but offering HIV testing presents a whole new realm of possibilities and challenges.

(THE NEWS: Walgreens to provide free HIV testing in CDC pilot. For the full story, click here.)

June 29, 2012

Drug maker Gilead Sciences has submitted a regulatory approval application to the Food and Drug Administration for a drug designed to increase the blood levels of certain drugs for HIV.

FOSTER CITY, Calif. — Drug maker Gilead Sciences has submitted a regulatory approval application to the Food and Drug Administration for a drug designed to increase the blood levels of certain drugs for HIV.

June 26, 2012

Walgreens is partnering with health authorities and service organizations to provide pharmacist-administered testing for the virus that causes AIDS, the retail pharmacy chain said.

DEERFIELD, Ill. — Walgreens is partnering with health authorities and service organizations to provide pharmacist-administered testing for the virus that causes AIDS, the retail pharmacy chain said.

The company is participating in a Centers for Disease Control and Prevention pilot with Greater Than AIDS and other organizations and local officials to expand HIV testing services and connect more people with the virus to treatment and care.

June 21, 2012

The Food and Drug Administration has approved a branded acne drug made by Ranbaxy Labs, the drug maker said. Ranbaxy announced the FDA approval of Absorica (isotretinoin), a drug for treating severe recalcitrant nodular acne.

The Food and Drug Administration has approved a branded acne drug made by Ranbaxy Labs, the drug maker said. Ranbaxy announced the FDA approval of Absorica (isotretinoin), a drug for treating severe recalcitrant nodular acne. The company expects to launch it in the United States in fourth quarter 2012 under an agreement with Canada-based Cipher Pharmaceuticals.


June 18, 2012

Walgreens and Greater Than AIDS, a coalition of public and private sector partners united in response to the domestic epidemic, are teaming with health departments and local AIDS organizations to provide free HIV testing at 47 Walgreens stores in 20 cities across the nation in June in support of National HIV Testing Day on June 27, the companies announced last week.

DEERFIELD, Ill. — Walgreens and Greater Than AIDS, a coalition of public and private sector partners united in response to the domestic epidemic, are teaming with health departments and local AIDS organizations to provide free HIV testing at 47 Walgreens stores in 20 cities across the nation in June in support of National HIV Testing Day on June 27, the companies announced last week.

May 23, 2012

A generic antiretroviral drug for treating HIV infection has won approval from the Food and Drug Administration.

PITTSBURGH — A generic antiretroviral drug for treating HIV infection has won approval from the Food and Drug Administration.

Mylan announced Wednesday the approval of nevirapine tablets in the 200-mg strength. The drug is a generic version of Boehringer Ingelheim's Viramune. Mylan plans to begin shipping the drug immediately.

Various versions of the drug had sales of $116.6 million during the 12-month period ended in March, according to IMS Health.

 

May 16, 2012

OraSure Technologies on Tuesday announced that the Food and Drug Administration's Blood Products Advisory Committee recommended that the OraQuick In-Home HIV test be made available without a prescription.

BETHLEHEM, Pa. — OraSure Technologies on Tuesday announced that the Food and Drug Administration's Blood Products Advisory Committee recommended that the OraQuick In-Home HIV test be made available without a prescription.

“There was broad support expressed by the HIV community at [the] meeting, and we look forward to continuing our work with them in the fight against HIV," stated OraSure president and CEO Douglas Michels. "We believe the OraQuick In-Home HIV Test will make a valuable contribution in this fight.”

May 14, 2012

A Food and Drug Administration expert panel has recommended approval of a drug made by Gilead Sciences for treating HIV, the drug maker said Friday.

FOSTER CITY, Calif. — Gilead Sciences scored a second favorable Food and Drug Administration expert panel vote as the FDA's Antiviral Drugs Advisory Committee recommended on Friday that the regulatory agency approve an experimental drug designed to treat HIV.

May 14, 2012

Schnuck Markets is opening a stand-alone pharmacy at a hospital in Illinois with an emphasis on specialty pharmacy services, the supermarket operator said.

SPRINGFIELD, Ill. — Schnuck Markets is opening a stand-alone pharmacy at a hospital in Illinois with an emphasis on specialty pharmacy services, the supermarket operator said.

Schnucks said the 2,000-sq.-ft. pharmacy at the pavilion of St. John's Hospital in Springfield, Ill., would be its first stand-alone specialty pharmacy in Illinois, specializing in such conditions as HIV, hepatitis, autoimmune disorders, organ transplants and cancers. The pharmacy replaces the specialty pharmacy at a nearby store, though the store's traditional pharmacy will remain.

May 11, 2012

An expert panel at the Food and Drug Administration has recommended that the agency approve a drug made by Gilead Sciences for lowering the risk of infection by the virus that causes AIDS.

FOSTER CITY, Calif. — An expert panel at the Food and Drug Administration has recommended that the agency approve a drug made by Gilead Sciences for lowering the risk of infection by the virus that causes AIDS.

May 11, 2012

As many as 74% of consumers would support a rapid, oral swab HIV test available over the counter, according to a survey released Friday by Who's Positive, a national HIV awareness organization.

WASHINGTON, D.C. — As many as 74% of consumers would support a rapid, oral swab HIV test available over the counter, according to a survey released Friday by Who's Positive, a national HIV awareness organization.

May 9, 2012

The Food and Drug Administration may be close to approving a drug for preventing HIV infection, according to published reports.

NEW YORK — The Food and Drug Administration may be close to approving a drug for preventing HIV infection, according to published reports.

The Associated Press reported that the FDA had said Truvada (emtricitabine and tenofovir disoproxil fumarate), made by Gilead Sciences, appeared to be safe and effective for preventing HIV infection when taken daily. An FDA advisory committee will review the drug and decide whether to recommend its approval for pre-exposure prophylaxis, or PrEP.

May 7, 2012

Walgreens just took another leap forward in its drive to become America’s “first choice for health and daily living” and “a centerpiece in improving patients’ overall health.”

Walgreens just took another leap forward in its drive to become America’s “first choice for health and daily living” and “a centerpiece in improving patients’ overall health.”

April 5, 2012

OraSure Technologies on Wednesday announced that the Food and Drug Administration's Blood Products Advisory Committee will consider making its OraQuick Rapid HIV-1/2 test available over the counter on May 15.

BETHLEHEM, Pa. — OraSure Technologies on Wednesday announced that the Food and Drug Administration's Blood Products Advisory Committee will consider making its OraQuick Rapid HIV-1/2 test available over the counter on May 15.

At the meeting, OraSure will present its consumer-usage studies — approximately 5,800 subjects were enrolled and tested in this phase across 20 states, the company said, which helped identify more than 100 previously undiagnosed individuals.

March 27, 2012

The Food and Drug Administration has approved a drug made by Johnson & Johnson for treating HIV in children.

TITUSVILLE, N.J. — The Food and Drug Administration has approved a drug made by Johnson & Johnson for treating HIV in children.

J&J's Janssen Therapeutics division announced Tuesday the FDA approval of Intelence (etravirine) in patients ages 6 years to younger than 18 years with HIV-1 who have taken other therapies but whose infection has become resistant to treatment. The drug already was approved for adults.

February 23, 2012

The Food and Drug Administration has given tentative approval to a division of Mylan for a generic drug for treating HIV and AIDS in children in developing countries.

PITTSBURGH — The Food and Drug Administration has given tentative approval to a division of Mylan for a generic drug for treating HIV and AIDS in children in developing countries.

Mylan said Thursday that the FDA had tentatively approved Mylan Labs' abacavir sulfate and lamivudine tablets in the 60 mg/30 mg strength. The drug is a generic version of Viiv Healthcare's Epzicom and was approved under the President's Emergency Plan for AIDS Relief. The drug will only be available for purchase in certain developing countries outside the United States.

February 14, 2012

The Food and Drug Administration is giving priority review to a drug made by Gilead Sciences that the company is investigating for the prevention of HIV.

FOSTER CITY, Calif. — The Food and Drug Administration is giving priority review to a drug made by Gilead Sciences that the company is investigating for the prevention of HIV.

Gilead said the FDA gave the special designation to its application for Truvada (emtricitabine and tenofovir disoproxil fumarate) for pre-exposure prophylaxis, or PrEP, to reduce the risk of HIV infection. The FDA originally approved Truvada for treating HIV infection in 2004, and it is currently the most prescribed antiretroviral drug in the United States.

January 19, 2012

The Food and Drug Administration has approved a lower-dose formulation of a drug made by Gilead Sciences for treating HIV in children, the company said.

FOSTER CITY, Calif. — The Food and Drug Administration has approved a lower-dose formulation of a drug made by Gilead Sciences for treating HIV in children, the company said.

Gilead announced the FDA approval of Viread (tenofovir disoproxil fumarate) in the 150-mg, 200-mg and 250-mg strengths combined with other antiretroviral drugs in patients ages 6 to 12 years while also approving an oral powder formulation for children ages 2 to 5 years. The agency approved the drug in the 300-mg strength for adults in 2001 and for patients ages 12 to 17 years in 2010.